Publication: Induced pluripotent stem cells in hematology: current and future applications
Loading...
Open/View Files
Date
2014
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Nature Publishing Group
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Focosi, D, G Amabile, A Di Ruscio, P Quaranta, D G Tenen, and M Pistello. 2014. “Induced pluripotent stem cells in hematology: current and future applications.” Blood Cancer Journal 4 (5): e211. doi:10.1038/bcj.2014.30. http://dx.doi.org/10.1038/bcj.2014.30.
Abstract
Reprogramming somatic cells into induced pluripotent stem (iPS) cells is nowadays approaching effectiveness and clinical grade. Potential uses of this technology include predictive toxicology, drug screening, pathogenetic studies and transplantation. Here, we review the basis of current iPS cell technology and potential applications in hematology, ranging from disease modeling of congenital and acquired hemopathies to hematopoietic stem and other blood cell transplantation.
Description
Other Available Sources
Research Data
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service